Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

TGF-β1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug

E. Slabáková, Z. Pernicová, E. Slavíčková, A. Staršíchová, A. Kozubík, K. Souček,

. 2011 ; 71 (12) : 1332-43. [pub] 20110214

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NS9600 MZ0 CEP Register
NS9956 MZ0 CEP Register

BACKGROUND: Epithelial-mesenchymal transition (EMT) underlying cancer cell invasion and metastasis has been thoroughly studied in prostate cancer. Although EMT markers have been clinically observed in benign prostate hyperplasia, molecular events underlying the onset and progression of EMT in benign prostate cells have not been described. METHODS: EMT in BPH-1 cells was induced by TGF-β1 treatment and the kinetics of expression of EMT markers, regulators, and selected miRNAs was assessed by western blotting and quantitative RT-PCR. RESULTS: EMT in BPH-1 cells was accompanied by rapid up-regulation of SNAI2/Slug and ZEB1 transcription factors, while changes in expression levels of ZEB2 and miR-200 family members were observed after extended time intervals. Invasive phenotype with EMT hallmarks, characterizing tumorigenic clones derived from BPH-1 cells, was associated with increased mRNA levels of SNAI2, ZEB1, and ZEB2, but was not associated with significant changes in basal levels of miR-200 family members. RNA interference revealed that SNAI2/Slug is crucial for TGF-β1-induced vimentin up-regulation and migration of BPH-1 cells. CONCLUSIONS: This study suggests that in BPH-1 cells the transcription factor SNAI2/Slug is important for EMT initiation, while the ZEB family of transcription factors in cooperation with the miR-200 family may oppose the reversal of the EMT phenotype.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027818
003      
CZ-PrNML
005      
20141113113638.0
007      
ta
008      
120817e20110214xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1002/pros.21350 $2 doi
035    __
$a (PubMed)21321977
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Slabáková, Eva $u Department of Cytokinetics, Academy of Sciences of the Czech Republic, Brno, Czech Republic
245    10
$a TGF-β1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug / $c E. Slabáková, Z. Pernicová, E. Slavíčková, A. Staršíchová, A. Kozubík, K. Souček,
520    9_
$a BACKGROUND: Epithelial-mesenchymal transition (EMT) underlying cancer cell invasion and metastasis has been thoroughly studied in prostate cancer. Although EMT markers have been clinically observed in benign prostate hyperplasia, molecular events underlying the onset and progression of EMT in benign prostate cells have not been described. METHODS: EMT in BPH-1 cells was induced by TGF-β1 treatment and the kinetics of expression of EMT markers, regulators, and selected miRNAs was assessed by western blotting and quantitative RT-PCR. RESULTS: EMT in BPH-1 cells was accompanied by rapid up-regulation of SNAI2/Slug and ZEB1 transcription factors, while changes in expression levels of ZEB2 and miR-200 family members were observed after extended time intervals. Invasive phenotype with EMT hallmarks, characterizing tumorigenic clones derived from BPH-1 cells, was associated with increased mRNA levels of SNAI2, ZEB1, and ZEB2, but was not associated with significant changes in basal levels of miR-200 family members. RNA interference revealed that SNAI2/Slug is crucial for TGF-β1-induced vimentin up-regulation and migration of BPH-1 cells. CONCLUSIONS: This study suggests that in BPH-1 cells the transcription factor SNAI2/Slug is important for EMT initiation, while the ZEB family of transcription factors in cooperation with the miR-200 family may oppose the reversal of the EMT phenotype.
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a buněčné linie $7 D002460
650    _2
$a pohyb buněk $7 D002465
650    _2
$a epitelo-mezenchymální tranzice $x genetika $7 D058750
650    _2
$a homeodoménové proteiny $x genetika $7 D018398
650    _2
$a lidé $7 D006801
650    _2
$a kinetika $7 D007700
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x metabolismus $7 D035683
650    _2
$a invazivní růst nádoru $x genetika $7 D009361
650    _2
$a fenotyp $7 D010641
650    _2
$a hyperplazie prostaty $x patofyziologie $7 D011470
650    _2
$a messenger RNA $x metabolismus $7 D012333
650    _2
$a represorové proteiny $x genetika $7 D012097
650    _2
$a transkripční faktory $x biosyntéza $x genetika $7 D014157
650    _2
$a transformující růstový faktor beta1 $x farmakologie $7 D053773
650    _2
$a upregulace $x účinky léků $7 D015854
650    _2
$a vimentin $x metabolismus $7 D014746
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pernicová, Zuzana $u Department of Cytokinetics, Academy of Sciences of the Czech Republic, Brno, Czech Republic
700    1_
$a Slavíčková, Eva $u Department of Cytokinetics, Academy of Sciences of the Czech Republic, Brno, Czech Republic
700    1_
$a Staršíchová, Andrea $u Department of Cytokinetics, Academy of Sciences of the Czech Republic, Brno, Czech Republic
700    1_
$a Kozubík, Alois $u Department of Cytokinetics, Academy of Sciences of the Czech Republic, Brno, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Souček, Karel $u Department of Cytokinetics, Academy of Sciences of the Czech Republic, Brno, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
773    0_
$w MED00010484 $t The Prostate $x 1097-0045 $g Roč. 71, č. 12 (20110214), s. 1332-43
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21321977 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20141113113652 $b ABA008
999    __
$a ok $b bmc $g 949860 $s 785164
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 71 $c 12 $d 1332-43 $e 20110214 $i 1097-0045 $m The Prostate $n Prostate $x MED00010484
GRA    __
$a NS9600 $p MZ0
GRA    __
$a NS9956 $p MZ0
LZP    __
$a Pubmed-20120817/11/03

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...